PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-02-24 (6)

Date Title Company
24-Feb-2026 Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer Businesswire